Abstract
Histone deacetylase (HDAC) has been highlighted as one of key players in tumorigenesis and angiogenesis. Recently, several derivatives of psammaplin (Psams) from a marine sponge have been known to inhibit the HDAC activity, but the molecular mechanism for the inhibition has not fully understood. Here, we explored the mode of action of Psams for the inhibition of HDAC activity in the molecular and cellular level. Among the derivatives, psammaplin A (Psam A) showed the potent inhibitory activity in enzyme assay and anti-proliferation assay with IC50 value of 0.003 and 1 µM, respectively. Psam A selectively induced hyperacetylation of histones in the cells, resulting in the upregulation of gelsolin, a well-known HDAC target gene, in a transcriptional level. In addition, reduced Psam A showed a stronger inhibitory activity than that of non-reduced one. Notably, glutathione-depleted cells were not sensitive to Psam A, implying that cellular reduction of the compound is responsible for the HDAC inhibition of Psam A after uptake into the cells. Together, these data demonstrate that Psam A could exhibit its activity under the reduced condition in the cells and be a new natural prodrug targeting HDAC.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Kim, D., Shin, J. & Kwon, H. Psammaplin A is a natural prodrug that inhibits class I histone deacetylase. Exp Mol Med 39, 47–55 (2007). https://doi.org/10.1038/emm.2007.6
Published:
Issue Date:
DOI: https://doi.org/10.1038/emm.2007.6
Keywords
This article is cited by
-
Progress in discovery and development of natural inhibitors of histone deacetylases (HDACs) as anti-cancer agents
Naunyn-Schmiedeberg's Archives of Pharmacology (2024)
-
DNMT (DNA methyltransferase) inhibitors radiosensitize human cancer cells by suppressing DNA repair activity
Radiation Oncology (2012)
-
Pharmacokinetics and tissue distribution of psammaplin A, a novel anticancer agent, in mice
Archives of Pharmacal Research (2012)
-
Histone deacetylase modulators provided by Mother Nature
Genes & Nutrition (2012)